ReviewJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2021
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
Open access · bronzeAbstract readReviewConsensus Statement
In one paragraph
Review in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.
- Mexican position paper for the diagnosis and treatment of cardiac amyloidosis.Archivos de cardiologia de Mexico · 2024Guideline
- The Return of Thallium-201 for American Patients: History, Radiopharmaceutical Features, and Current Applications.Current cardiology reports · 2026Review
- Evaluation of the diagnostic value of dual-time-point, multi-parameter 99mTc-PYP imaging in diagnosing Transthyretin Cardiac Amyloidosis.The international journal of cardiovascular imaging · 2026Article
- Diagnostic Accuracy of Bisphosphonate Scintigraphy in Glu54GlnATTR Cardiomyopathy.Journal of clinical medicine · 2025Article
- Clinical significance of quantitative assessment of right ventricular amyloid burden with [European journal of nuclear medicine and molecular imaging · 2025Article
- The Accuracy of Technetium-99 m Pyrophosphate Imaging in Diagnosing Transthyretin Cardiac Amyloidosis and Its Impact on Patient Management.Current cardiology reports · 2025Review
- Evolution of cardiac amyloidosis imaging with bone-avid tracers: From qualification to quantification.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2024Article
- Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis.Annals of clinical and translational neurology · 2024Article
- Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy.Scientific reports · 2024Article
- Cardiac scintigraphy and echocardiography assessment in the diagnosis of transthyretin cardiac amyloidosis.The international journal of cardiovascular imaging · 2024Article
- Transthyretin amyloid cardiomyopathy disease burden quantified usingJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Looking inside AND outside the heart.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Don't judge a book by its cover: a case report of apolipoprotein A-IV cardiac amyloidosis.European heart journal. Case reports · 2023Article
- Efficacy of Tafamidis in Patients with Ala97Ser Hereditary Transthyretin Cardiac Amyloidosis: A Six-Month Follow-Up Study.Acta Cardiologica Sinica · 2023Article
- Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2022: positron emission tomography, computed tomography, and magnetic resonance.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Review
- Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Echocardiographic indices of left ventricular function and filling pressure are not related to blood pool activity on pyrophosphate scintigraphy.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 20 institutions in 7 countries.
Sharmila DorbalaCardiac Amyloidosis Program, Cardiovascular Imaging Programs, Departments of Medicine and Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Yukio AndoDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Sabahat BokhariColumbia University Medical Center, New York Presbyterian Hospital, Columbia University, New York, NY, USA.
Angela DispenzieriDivision of Hematology, Division of Cardiovascular Diseases, Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Rodney H FalkCardiac Amyloidosis Program, Cardiovascular Imaging Programs, Departments of Medicine and Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Victor A FerrariPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Marianna FontanaDivision of Medicine, National Amyloidosis Centre, University College London, London, UK.
Olivier GheysensUniversity Hospitals Leuven, Nuclear Medicine and Molecular Imaging, Leuven, Belgium.
Julian D GillmoreDivision of Medicine, National Amyloidosis Centre, University College London, London, UK.
Andor W J M GlaudemansDepartment of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Mazen A HannaDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Bouke P C HazenbergDepartment of Rheumatology & Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Arnt V KristenDepartment of Cardiology, University of Heidelberg, Heidelberg, Germany.
Raymond Y KwongCardiac Amyloidosis Program, Cardiovascular Imaging Programs, Departments of Medicine and Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Mathew S MaurerColumbia University Medical Center, New York Presbyterian Hospital, Columbia University, New York, NY, USA.
Giampaolo MerliniFoundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Amyloidosis Research and Treatment Center, Pavia, Italy.
Edward J MillerCardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
James C MoonDivision of Medicine, National Amyloidosis Centre, University College London, London, UK.
Venkatesh L MurthyFrankel Cardiovascular Center, Michigan Medicine, Ann Arbor, MI, USA.
C Cristina QuartaDivision of Medicine, National Amyloidosis Centre, University College London, London, UK.
Claudio RapezziCardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.
Frederick L RubergDepartment of Medicine, Amyloidosis Center and Section of Cardiovascular Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.
Sanjiv J ShahFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Riemer H J A SlartDepartment of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Hein J VerberneDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Jamieson M BourqueDepartments of Medicine and Radiology, Cardiovascular Imaging Center, University of Virginia, Charlottesville, VA, USA. JMB8T@hscmail.mcc.virginia.edu.
University College London · GBBrigham and Women's Hospital · USUniversity of Groningen · NLBoston University · USCleveland Clinic · USColumbia University Irving Medical Center · USHarvard University · USHeidelberg University · DEImaging Center · USIstituti di Ricovero e Cura a Carattere Scientifico · ITKU Leuven · BEKumamoto University · JPMayo Clinic in Arizona · USMichigan Medicine · USNewYork–Presbyterian Hospital · USNorthwestern University · USUniversity Medical Center Groningen · NLUniversity of Amsterdam · NLUniversity of Bologna · ITUniversity of Pennsylvania · US
Funding
British Heart Foundation FS/18/21/33447
Abstract
PubMed holds no abstract for this paper.
Indexed as
Cardiac Imaging TechniquesMultimodal ImagingAmyloidosisCardiomyopathiesHumans
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.